Immunoexpression of CXCL12 and CXCR4 in sporadic and Gorlin-Goltz syndrome-related odontogenic keratocysts.

Wliana-Pontes de Lima, Allany-de Oliveira Andrade, Roberta-Barroso Cavalcante, Renato-Luiz-Maia Nogueira, Pollianna-Muniz Alves, Cassiano-Francisco-Weege Nonaka, Manuel-Antonio Gordón-Núñez
Author Information
  1. Wliana-Pontes de Lima: Universidade Estadual da Paraíba - UEPB, Department of Dentistry, Campina Grande, PB, Brazil.
  2. Allany-de Oliveira Andrade: Universidade Estadual da Paraíba - UEPB, Department of Dentistry, Campina Grande, PB, Brazil.
  3. Roberta-Barroso Cavalcante: Universidade de Fortaleza - UNIFOR, Department of Oral Pathology, Fortaleza, CE, Brazil.
  4. Renato-Luiz-Maia Nogueira: Universidade Federal do Ceará - UFC, Department of Dental Clinic, Fortaleza, CE, Brazil.
  5. Pollianna-Muniz Alves: Universidade Estadual da Paraíba - UEPB, Department of Dentistry, Campina Grande, PB, Brazil.
  6. Cassiano-Francisco-Weege Nonaka: Universidade Estadual da Paraíba - UEPB, Department of Dentistry, Campina Grande, PB, Brazil.
  7. Manuel-Antonio Gordón-Núñez: Universidade Estadual da Paraíba - UEPB, Department of Dentistry, Campina Grande, PB, Brazil.

Abstract

Background: Differences in the pathogenesis and biological behavior of sporadic and Gorlin-Goltz syndrome-related odontogenic keratocysts (OKCs) have been reported, but the underlying mechanisms are not fully elucidated. Chemokine CXCL12 and its main receptor CXCR4 regulate important events in the pathogenesis of several lesions.
Material and Methods: This study evaluated the immunoexpression of CXCL12 and CXCR4 in sporadic and syndromic OKCs. Twenty-two sporadic OKCs and 22 syndromic OKCs were subjected to immunohistochemistry. The percentages of cytoplasmic (CXCL12 and CXCR4) and nuclear (CXCR4) staining in epithelial and fibrous capsule cells were determined. The results were analyzed statistically using the nonparametric Mann-Whitney test and Spearman correlation test (<0.05).
Results: Higher cytoplasmic expression of CXCL12 was observed in the epithelial lining and fibrous capsule of sporadic OKCs compared to syndromic OKCs (<0.001). No statistically significant differences in the cytoplasmic expression of CXCR4 were observed between syndromic OKCs and sporadic OKCs (>0.05). Compared to syndromic OKCs, sporadic OKCs exhibited higher nuclear expression of CXCR4 in the epithelial lining and lower immunoexpression in the fibrous capsule (<0.05). In the epithelial lining of syndromic OKCs, positive correlation was observed between cytoplasmic and nuclear expressions of CXCR4 (=0.003). In the fibrous capsule of syndromic OKCs and sporadic OKCs, cytoplasmic and nuclear expressions of CXCR4 were positively correlated (<0.001).
Conclusions: The results suggest a potential participation of CXCL12 and CXCR4 in the development of OKCs. The heterogeneous expression of these proteins in syndromic and sporadic OKCs may reflect differences in their pathogenesis and biological behavior. Odontogenic keratocyst, CXCL12, CXCR4, Immunohistochemistry.

References

Clin Transl Radiat Oncol. 2017 Jul 14;5:28-36 [PMID: 29594214]
J Craniofac Surg. 2016 Jul;27(5):1361-6 [PMID: 27391504]
J Craniomaxillofac Surg. 2015 Jul;43(6):733-7 [PMID: 25976039]
J Am Soc Nephrol. 2009 Aug;20(8):1714-23 [PMID: 19443644]
Cytokine Growth Factor Rev. 2018 Dec;44:51-68 [PMID: 30396776]
Cancer Res. 2006 Feb 15;66(4):2181-7 [PMID: 16489019]
Sci Rep. 2017 Aug 31;7(1):10286 [PMID: 28860570]
Actas Dermosifiliogr (Engl Ed). 2018 Apr;109(3):207-217 [PMID: 29373110]
Am J Physiol Gastrointest Liver Physiol. 2011 Dec;301(6):G968-80 [PMID: 21921288]
PLoS One. 2014 Aug 14;9(8):e104746 [PMID: 25121739]
Virchows Arch. 2018 Mar;472(3):331-339 [PMID: 28674741]
J Med Genet. 1993 Jun;30(6):460-4 [PMID: 8326488]
J Endod. 2013 Oct;39(10):1234-9 [PMID: 24041383]
Nat Rev Immunol. 2013 Nov;13(11):815-29 [PMID: 24319779]
Front Immunol. 2020 Aug 28;11:2109 [PMID: 32983169]
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20009-14 [PMID: 21041659]
J Diabetes Metab Disord. 2019 Jul 29;18(2):371-378 [PMID: 31890662]
J Endod. 2018 May;44(5):728-733 [PMID: 29510866]
Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G316-26 [PMID: 15358596]
Oral Dis. 2020 Apr;26(3):711-715 [PMID: 31917876]
Braz Oral Res. 2017 Apr 27;31:e34 [PMID: 28489118]
J Leukoc Biol. 2020 Jun;107(6):1123-1135 [PMID: 32374043]
Oral Microbiol Immunol. 2009 Feb;24(1):25-31 [PMID: 19121066]
J Biol Chem. 2017 Jan 6;292(1):31-42 [PMID: 27875312]
J Exp Med. 2018 Jan 2;215(1):303-318 [PMID: 29203538]
Clin Cancer Res. 2015 Oct 1;21(19):4278-85 [PMID: 26199389]
Pharmaceuticals (Basel). 2020 Feb 21;13(2): [PMID: 32098047]
Arch Oral Biol. 2012 Mar;57(3):230-7 [PMID: 21871606]
Carcinogenesis. 2018 Apr 5;39(4):588-600 [PMID: 29390073]

Word Cloud

Similar Articles

Cited By